bpc 157 tb 500 blend side effects Wolverine Peptide Therapy in South Florida | BPC-157 & TB-500 bpc-157 tb-500 blend side effects

Unexpected cloudiness, discoloration, or persistent particulate matter should be investigated before the material is used in laboratory work

## **Documentation requirements for J1815** As with any procedure, especially involving injecting drugs into patients, it's important to document the following before you file for a claim that includes this code: - The full name of the personnel who administered the injection + their credentials - The name and address of the facility where the injection was administered - The full name of the patient - The dates and times of the administration by injection - Patient records showing their diabetes diagnosis and related conditions and symptoms - Records of insulin products that the patient uses - Records of their blood glucose levels - The exact dosage(s) of the insulin shots ## **Billing requirements for J1815** Besides the documentation requirements above, please note the following billing requirements for this HCPCS code: - They must reflect the dosage given over the course of the treatment

70% alcohol swabs Two swabs to disinfect the peptide vial and the solvent vial

Were always available to discuss what approach might work best for your situation

Standard Concentration: 2-5% AHK-Cu For most people, a 25% AHK-CU concentration is the sweet spot

PubMed laboratory research record [PMID: 24666754] PubMed record related to this compound for laboratory literature review